Literature DB >> 9407947

Mutations of the MEN1 tumor suppressor gene in pituitary tumors.

Z Zhuang1, S Z Ezzat, A O Vortmeyer, R Weil, E H Oldfield, W S Park, S Pack, S Huang, S K Agarwal, S C Guru, P Manickam, L V Debelenko, M B Kester, S E Olufemi, C Heppner, J S Crabtree, A L Burns, A M Spiegel, S J Marx, S C Chandrasekharappa, F S Collins, M R Emmert-Buck, L A Liotta, S L Asa, I A Lubensky.   

Abstract

Although pituitary adenomas are monoclonal proliferations, somatic mutations involving genes that govern cell proliferation or hormone production have been difficult to identify. The genetic etiology of most pituitary tumors, therefore, remains unknown. Pituitary adenomas can develop sporadically or as a part of multiple endocrine neoplasia type 1 (MEN1). Recently, the gene responsible for MEN1 was cloned. To elucidate the potential etiological role of the MEN1 gene in pituitary tumorigenesis, 39 sporadic pituitary adenomas from 38 patients and 1 pituitary adenoma from a familial MEN1 patient were examined for MEN1 gene mutations and allelic deletions. Four of 39 sporadic pituitary adenomas showed a deletion of one copy of the MEN1 gene, and a specific MEN1 gene mutation in the remaining gene copy was detected in 2 of these tumors. The corresponding germ-line sequence was normal in all sporadic cases. A specific MEN1 mutation was detected in a pituitary adenoma and corresponding germ-line DNA in a patient with familial MEN1. An allelic deletion of the remaining copy of the MEN1 gene was also found in the patient's tumor. Genetic alterations of the MEN1 gene represent a candidate pathogenetic mechanism of pituitary tumorigenesis. The data suggest that somatic MEN1 gene mutations and deletions play a causative role in the development of a subgroup of sporadic pituitary adenomas.

Entities:  

Mesh:

Year:  1997        PMID: 9407947

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

1.  Neurological surgery at the National Institutes of Health.

Authors:  Gautam U Mehta; John D Heiss; John K Park; Ashok R Asthagiri; Kareem A Zaghloul; Russell R Lonser
Journal:  World Neurosurg       Date:  2010-07       Impact factor: 2.104

2.  The Art and Applications of Fluorescence In Situ Hybridization in Endocrine Pathology.

Authors:  George Kontogeorgos
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

3.  Menin immunoreactivity in secretory granules of human pancreatic islet cells.

Authors:  Larisa V Debelenko; Sunita Agarwal; Qiang Du; Wusheng Yan; Heidi S Erickson; Mones Abu-Asab; Mark A Raffeld; Steven K Libutti; Stephen J Marx; Michael R Emmert-Buck
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014 Nov-Dec

4.  A novel germline mutation of MEN 1 gene in a patient with acromegaly and multiple endocrine tumors.

Authors:  G Pinna; G Orgiana; C Carcassi; F Alba; F Cetani; E Pardi; C Marcocci; S Mariotti
Journal:  J Endocrinol Invest       Date:  2004-06       Impact factor: 4.256

Review 5.  Pathogenesis of prolactinomas.

Authors:  Anna Spada; Giovanna Mantovani; Andrea Lania
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

6.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors.

Authors:  J S Crabtree; P C Scacheri; J M Ward; L Garrett-Beal; M R Emmert-Buck; K A Edgemon; D Lorang; S K Libutti; S C Chandrasekharappa; S J Marx; A M Spiegel; F S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-30       Impact factor: 11.205

7.  Menin, the product of the MEN1 gene, is a nuclear protein.

Authors:  S C Guru; P K Goldsmith; A L Burns; S J Marx; A M Spiegel; F S Collins; S C Chandrasekharappa
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

Review 8.  Mechanisms for pituitary tumorigenesis: the plastic pituitary.

Authors:  Shlomo Melmed
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

9.  MEN1 gene alterations do not correlate with the phenotype of sporadic primary hyperparathyroidism.

Authors:  F Cetani; E Pardi; E Vignali; S Borsari; A Picone; L Cianferotti; E Ambrogini; P Miccoli; A Pinchera; C Marcocci
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

10.  Of mice and MEN1: Insulinomas in a conditional mouse knockout.

Authors:  Judy S Crabtree; Peter C Scacheri; Jerrold M Ward; Sara R McNally; Gary P Swain; Cristina Montagna; Jeffrey H Hager; Douglas Hanahan; Helena Edlund; Mark A Magnuson; Lisa Garrett-Beal; A Lee Burns; Thomas Ried; Settara C Chandrasekharappa; Stephen J Marx; Allen M Spiegel; Francis S Collins
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.